Diphenylhydantoin elimination kinetics in overdosed children

Diphenylhydantoin (DPH) elimination was studied in 4 overdosed children who presented with serum concentrations ranging from 44 to 76 mg/l. Serum was assayed for DPH and urine was assayed for both DPH and 5‐(p‐hydroxyphenyl)‐5‐phenylhydantoin (HPPH). The serum and urine data were subjected to simultaneous computer nonlinear regression analysis using a one‐compartment pharmacokinetic model, which accounts for much of the known disposition kinetics of DPH. Computed va lues for the apparent in vivo Michaelis‐Menten constants, KM and V max, were compared with values derived from data in the literature for normal adult subjects. A trend toward relatively lower KM and higher V max/KM values was seen in children. Patients with higher Vmax values had greater urinary excretion rates of HPPH which, at high serum levels of DP H, were relatively constant except jor an apparent diurnal rhythm. The time of onset of DPH toxicity in the children was related to the magnitude by which the rate of DPH administration exceeded the Vmax values.

[1]  M. Ede Circadian rhythms of drug effectiveness and toxicity , 1973, Clinical pharmacology and therapeutics.

[2]  J. M. Sutherland,et al.  The renal handling of diphenylhydantoin and 5‐(p‐hydroxyphenyl)‐5‐phenylhydantoin , 1973, Clinical pharmacology and therapeutics.

[3]  J. M. Shaw,et al.  Pharmacokinetic study of a patient with diphenylhydantoin toxicity , 1973, Clinical pharmacology and therapeutics.

[4]  F. Bochner,et al.  Effect of dosage increments on blood phenytoin concentrations , 1972, Journal of neurology, neurosurgery, and psychiatry.

[5]  S. Louis,et al.  Diphenylhydantoin: efficacy, toxicity, and dose-serum level relationships in children. , 1972, The Journal of pediatrics.

[6]  J. Wagner,et al.  Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation. , 1972, Research communications in chemical pathology and pharmacology.

[7]  G. Levy,et al.  Relationship between dose and plateau levels of drugs eliminated by parallel first-order and capacity-limited kinetics. , 1972, Journal of pharmaceutical sciences.

[8]  N. Gerber,et al.  Intoxication with 5,5-diphenylhydantoin (Dilantin) , 1972 .

[9]  E. Horning,et al.  Detection of 5-(3, 4-Dihydroxy-1, 5-Cyclohexadien-1-Yl) -5-Phenylsydantoin as a Major Metabolite of 5, 5-Diphenylhydantoin (Dilantin) in the Newborn Human , 1971 .

[10]  A. Glazko,et al.  Colorimetric Assay of 5,5-Diphenylhydantoin (Dilantin 1 ) and 5- (p-Hydroxyphenyl)-5-phenylhydantoin , 1971 .

[11]  O. Kim,et al.  Apparent Saturation of Diphenylhydantoin Metabolism in Children , 1970, Pediatric Research.

[12]  H. Kupferberg Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatography. , 1970, Clinica chimica acta; international journal of clinical chemistry.

[13]  T. Suzuki,et al.  Kinetics of diphenylhydantoin disposition in man. , 1970, Chemical & pharmaceutical bulletin.

[14]  K. Arnold,et al.  The rate of decline of diphenylhydantoin in human plasma , 1970, Clinical pharmacology and therapeutics.

[15]  R. Buchanan,et al.  Absorption and elimination of ethosuximide in children. , 1969, The Journal of clinical pharmacology and the journal of new drugs.

[16]  J. Fujimoto,et al.  Urinary excretion of primidone and its metabolites in rabbits. , 1968, The Journal of pharmacology and experimental therapeutics.

[17]  H. F. Martin,et al.  Gas Chromatographic Identification and Determination of Barbiturates. , 1966 .

[18]  O. Borgå,et al.  Identification of 5-(3,4-dihydroxyphenyl)-5-phenylhydantoin as a metabolite of 5,5-diphenylhydantoin (phenytoin) in rats and man. , 1972, Pharmacology.

[19]  A. Glazko,et al.  Quantitative assay of 5,5-diphenylhydantoin (Dilantin) and 5-(p-hydroxyphenyl)-5-phenylhydantoin by gas-liquid chromatography. , 1970, The Journal of laboratory and clinical medicine.